Q Fever Market 2018 Major Venders: Yashica Pharmaceuticals Private Limited Merck & Co., Atox Bio, Teva Pharmaceutical Industries, Basilea Pharmaceutica

The, Q Fever Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The , Q Fever Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2023, outperforming its past development records as far as esteem and volume.

TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5490 .

The global Q fever market is expected to grow at a CAGR of 6.3% during the forecasted period

Market Scenario:
The infection caused by the bacterium Coxiella burnetii is termed as Q fever. Usually, Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.

The global Q fever market is majorly driven by increasing prevalence of chronic diseases, heart disease, continuously increasing geriatric population, and increasing number of patients suffering from a various bacterial infection. However, the growth of the market is restricted due to lack of awareness about Q fever and the high cost of treatment.

According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths of which 82% were in the low and middle-income countries. Additionally, according to the Centers for Disease Control and Prevention (2015), over 630,000 Americans died from heart disease each year, which accounts for one in every four death. According to findings from the WHO in 2014, approximately 422 million people reported suffering from diabetes. Due to the increasing diabetic population across the globe, there is a significant increase in the number of people suffering from cardiovascular diseases. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market.

On the other hand, strict regulatory rules and the high cost of the diagnostic tests may slow the growth of the market during the forecast period.

Key Players:
Some of the key players in Q fever market are Yashica Pharmaceuticals Private Limited (India) Merck & Co. (U.S.), Atox Bio (Israel), Teva Pharmaceutical Industries (Israel), Basilea Pharmaceutica Ltd. (Switzerland), and MELINTA THERAPEUTICS, INC. (U.S.), Pfizer (U.S.), Cipla Inc. (India), and others.

Regional Analysis:
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases. As per the Center for Disease Control & Prevention (CDC), in 2015, 28.4 million adults were diagnosed with cardiovascular diseases in the U.S. alone.

Europe is the second largest market and holds a noticeable share in the global Q fever market. The European market is expected to grow significantly during the forecast period owing to the availability of advanced treatment facilities, skilled medical professionals. Furthermore, extensive research and development activities for the treatment of rare disease, and increasing government support boosts the market growth.

Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases such as diabetes, cancer and bacterial infection in developing countries is the major driver for the market growth. China and India are the fastest growing regions owing to an increasing geriatric population. Also, the bacterial infection is one of the major chronic conditions affecting a large number of patients, thereby influencing the market growth. Rising awareness about the infections and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the market. According to the International Diabetic Federation, about 415 million people had diabetes across the globe in 2015, which is expected to reach 642 million by 2040. It also stated that 98.4 million and 65.1 million diabetic population lived in China and India, respectively. It stated that in 2015, 3.7% of the Asian population was diagnosed with chronic heart disease, while 21% of the people had hypertension.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness about the Q fever, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates has the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.

AVAIL AMAZING DISCOUNT ON REPPRT @ https://www.marketresearchfuture.com/check-discount/5490 .

Major Table Of Content:
Chapetr 1. Report Prologue

Chapetr 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapetr 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapetr 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapetr 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

…CONTINUED

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.